Gene · 6612
SUMO3: small ubiquitin like modifier 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SUMO3: small ubiquitin like modifier 3. Genes, record 6612. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6612
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P55854 | Small ubiquitin-related modifier 3 | 103 | 8 | Ensembl, GeneID, HGNC |
Source UniProt
Patents50
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4805378 A1 | 2026-09-16 | 100 | P55854 | Espacenet |
| JP 2026523341 A | 2026-07-14 | 559 | P55854 | Espacenet |
| EP 4771137 A1 | 2026-07-08 | 97 | P55854 | Espacenet |
| EP 4771157 A1 | 2026-07-08 | 97 | P55854 | Espacenet |
| JP 2026108757 A | 2026-06-30 | 34 | P55854 | Espacenet |
| US 12649003 B2 | 2026-06-09 | 559 | P55854 | Espacenet |
| JP 2026510339 A | 2026-04-02 | 97 | P55854 | Espacenet |
| EP 4713451 A2 | 2026-03-25 | 97 | P55854 | Espacenet |
| EP 4713452 A2 | 2026-03-25 | 97 | P55854 | Espacenet |
| US 12558437 B2 | 2026-02-24 | 559 | P55854 | Espacenet |
1 to 10 of 50
See all 50 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants917
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SUMO3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 7 | 2025 |
| T32CA009110 | Training in Areas Fundamental to Cancer Research | 6 | 2025 |
| R01CA073764 | FEN1-mediated Okazaki fragment maturation and its deficiency in cancer | 4 | 2025 |
| ZIAHD001310 | Gene Regulation In The Immune System | 4 | 2025 |
| P30CA093373 | Cancer Center Support Grant P30 | 3 | 2025 |
| P30DK050306 | Center for Molecular Studies in Digestive and Liver Diseases | 3 | 2025 |
| R01CA256543 | Targeting Constitutively Active SUMO Modified Androgen Receptors in Endocrine Resistant Breast Cancer | 3 | 2025 |
| R50CA211397 | Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers | 3 | 2025 |
| ZIATR000018 | Drug Repurposing Screening for Rare and Neglected Diseases | 3 | 2025 |
1 to 10 of 917Source NIH's project files
See all 917 nih grantsPapers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SEPT5 confers radioresistance by suppressing GSDME-dependent pyroptosis and antitumor immunity in non-small cell lung cancer. | Int Immunopharmacol | 2026 | 42743876 | PubTator, text mining | PubMed |
| SUMO3/RUNX1/AIRE/RCAN1 and DNMT3L/DYRK1A/Let-7c-5p/VEGF axes: immune dysregulation and genetic susceptibility as pulmonary risk factors in Down syndrome. | 3 Biotech | 2026 | 42245386 | PubTator, text mining | PubMed |
| Denaturing SUMO Immunoprecipitation From Mitotic Cells. | Bio Protoc | 2026 | 41971162 | PubTator, text mining | PubMed |
| Small Ubiquitin-Like Modifier 3 Attenuates Lung Ischemia-Reperfusion Injury Progression by Inhibiting Endoplasmic Reticulum Stress through Heat Shock Protein 70. | Am J Pathol | 2026 | 41881306 | PubTator, text mining | PubMed |
| Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation. | Proc Natl Acad Sci U S A | 2026 | 41871251 | PubTator, text mining | PubMed |
| Cellular strategies for repairing trapped protein-DNA complexes. | Front Pharmacol | 2026 | 41743125 | PubTator, text mining | PubMed |
| SUMOylation is destined for regulatory T cell-related immune dysregulation. | Cell Death Discov | 2026 | 41633969 | PubTator, text mining | PubMed |
| SUMOylation machinery protein, PIAS4 role in breast cancer cell proliferation and drug sensitivity. | Mol Biol Rep | 2026 | 41615552 | PubTator, text mining | PubMed |
| A single-cell derived spheroid approach to dissect intratumoural heterogeneity in colorectal cancer: cell lines show changes in proteomes and therapeutic response to 5-FU. | J Cancer Res Clin Oncol | 2026 | 41580526 | PubTator, text mining | PubMed |
| Down-regulation of EHMT2 through irisin-mediated epigenetic modification promotes osteogenesis via promoting DLX3 transcription. | Cell Commun Signal | 2026 | 41555399 | PubTator, text mining | PubMed |
1 to 10 of 1,564
See all 1,564 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6612
GET https://conductscience.org/api/genes/v1/6612/patents?page=2